Nasdaq:US$18.07 (-0.92) | HKEX:HK$30.35 (+0.00) | AIM:£2.90 (-0.14)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF